SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 305 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,989,000 | +34.3% | 33,191 | +16.0% | 0.72% | +17.8% |
| Q2 2021 | $2,225,000 | -54.0% | 28,625 | +0.9% | 0.61% | -64.9% |
| Q4 2020 | $4,838,000 | -5.9% | 28,378 | -28.7% | 1.74% | +7.8% |
| Q4 2019 | $5,139,000 | +801.6% | 39,822 | +961.1% | 1.62% | +619.6% |
| Q2 2019 | $570,000 | -66.7% | 3,753 | -73.9% | 0.22% | -66.8% |
| Q1 2019 | $1,712,000 | -27.4% | 14,364 | -33.5% | 0.68% | -45.7% |
| Q4 2018 | $2,359,000 | +72.7% | 21,615 | +155.6% | 1.25% | +105.1% |
| Q3 2018 | $1,366,000 | +54.0% | 8,456 | +25.9% | 0.61% | +57.9% |
| Q2 2018 | $887,000 | -67.3% | 6,714 | -86.2% | 0.38% | -53.6% |
| Q4 2017 | $2,715,000 | -11.1% | 48,800 | -27.5% | 0.83% | -10.3% |
| Q3 2017 | $3,053,000 | +1227.4% | 67,300 | +701.2% | 0.92% | +873.7% |
| Q4 2016 | $230,000 | – | 8,400 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |